Official announcements (8-K)

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

In the company's wordsOn November 4, 2026, Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and nine months ended September 30, 2026 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section …

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

In the company's wordsOn July 29, 2026, Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and six months ended June 30, 2026 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the …

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

In the company's wordsOn June 22, 2026, Ryan Cotterman, age 44, was appointed as Vice President, Chief Accounting Officer and principal accounting officer of Ingevity Corporation (the “Company”). Mr. Cotterman most recently served as Senior Director, Corporate Controller of Ralliant Corporation (NYSE: RAL), a publicly traded precision technology company spun off from Fortive Corporation (NYSE: FTV), which he joined in 2025. Prior to that, Mr. Cotterman served as Vice President, Corporate Controller of Cornerstone Building Brands, Inc. from 2023 to 2024. From 2017 to 2023, Mr. Cotterman held positions of increasing responsibility at Advance Auto Parts, Inc. (NYSE: AAP), most recently as Vice …

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

In the company's wordsOn May 6, 2026, Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three months ended March 31, 2026 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the …

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

In the company's wordsOn April 29, 2026, Ingevity Corporation (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, upon the recommendation of the Company’s Board of Directors, the Company’s stockholders approved the Amendment to the Ingevity Corporation 2025 Omnibus Incentive Plan (the “Amendment”). The Amendment increases the number of shares available for issuance under the plan by 580,000 shares. A description of the Amendment is contained in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 17, 2026, and the complete text of the Amendment is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Shared shareholder vote results (Item 5.07)

How shareholders voted on board members and proposals.

In the company's wordsAt the Annual Meeting, the Company’s stockholders voted on the four proposals identified below. Each of the proposals is described in more detail in the 2026 Proxy Statement. There were 35,222,538 shares of the Company’s common stock issued and outstanding on the record date and entitled to vote at the Annual Meeting, and 33,498,332 shares (95.10%) were represented in person or by proxy at the Annual Meeting, which number constituted a quorum. The final voting results for each proposal voted upon at the Annual Meeting are described below. 1.Election of the nine (9) director nominees listed below, each for a one-year term or until his or her successor is duly elected and …

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

In the company's wordsOn April 15, 2026, Ingevity Corporation (the “Company”) issued a press release announcing the completion of the Company’s sale of its road markings product line to PPG Industries Inc. A copy of the press release announcing the completion of the Company’s sale of the road markings product line is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”). The information furnished under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be …

Signed a major agreement (Item 1.01)

A major new contract can change what the company sells, spends or owes.

In the company's wordsA MATERIAL DEFINITIVE AGREEMENT On March 26, 2026 (the “Closing Date”), Ingevity Corporation (the “Company”), Ingevity Holdings SRL (“Holdings”), Ingevity UK Ltd (the “UK Borrower”), the other loan parties party thereto, the lenders party thereto, the issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), collateral agent and swingline lender, entered into that certain Second Amendment and Restatement Agreement (the “Amendment”), which amends and restates the Amended and Restated Credit Agreement, dated as of June 23, 2022 (the “Existing Credit Agreement,” and as amended and restated by the Amendment, the “Second …

Took on a major new debt or obligation (Item 2.03)

New borrowing adds to what the company owes and the interest it pays.

In the company's wordsa direct financial obligation or an obligation under an off-balance sheet arrangement of a registrant The information in Item 1.01 above is incorporated by reference into this Item 2.03.

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

In the company's wordsOn February 25, 2026, Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and twelve months ended December 31, 2025, which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of …

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

In the company's wordsBeginning with our 2025 Form 10-K, Ingevity will remove Corporate and other costs from our Segment Operating Results, which are recorded within "Selling, general, and administrative expenses" on our Consolidated Statements of Operations. These costs are associated with corporate administrative functions (e.g., executive office, corporate finance, legal, human resources) and other compliance costs to operate as a NYSE listed entity. Additionally, these costs are managed at a corporate level and not directly attributable to our reportable segments. Reporting these costs separately will provide greater transparency into our segment results and cost structure. Ingevity is …

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

In the company's wordsOn February 17, 2026, Jean S. Blackwell informed the Nominating & Governance Committee of the Board of Directors (the “Board”) of Ingevity Corporation (the “Company”) that she will not stand for election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). Ms. Blackwell will continue to serve as a director through the date of the 2026 Annual Meeting. Her decision not to stand for election at the 2026 Annual Meeting did not result from any disagreement with the Company on any matter relating to its operations, policies or practices. Daniel F. Sansone will not stand for election at the 2026 Annual Meeting in accordance with the retirement age …

Signed a major agreement (Item 1.01)

A major new contract can change what the company sells, spends or owes.

In the company's wordsInto a Material Definitive Agreement Amendment to Asset Purchase Agreement In connection with the Closing, on January 1, 2026, the Parties entered into the Amendment, which, among other things, modified the scope of assets being transferred pursuant to the Original Purchase Agreement by excluding non-lignin dispersant products sold to existing customers for agricultural chemical applications. Except to the extent specifically amended in, or supplemented by, the Amendment, the Purchase Agreement, which was filed as Exhibit 2.1 to the Previous Form 8-K, remains unchanged and in full force and effect. The foregoing summary of the Amendment does not purport to be complete and …

Completed buying or selling a business or major assets (Item 2.01)

Buying or selling a business changes what the company owns and how it earns money.

In the company's wordsof Acquisition or Disposition of Assets The information provided under the Introductory Note and Item 1.01 in this Current Report on Form 8-K are incorporated by reference into this Item 2.01. In accordance with the Purchase Agreement, on January 1, 2026, Buyer purchased substantially all of the assets and assumed and acquired certain of the rights and liabilities of Ingevity or its applicable affiliates that related to or are used in connection with (a) Ingevity’s industrial specialties product line (other than certain businesses and products more fully described in the Purchase Agreement) and (b) Ingevity’s North Charleston, South Carolina crude tall oil refinery and …

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

In the company's wordsFD Disclosure On January 5, 2026, Ingevity issued a press release announcing that it had completed the Transaction. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

In the company's wordsOfficers; Compensatory Arrangements of Certain Officers Chief Financial Officer Transition On December 8, 2025, Ingevity Corporation (“Ingevity” or the “Company”) announced that Mary Dean Hall, Executive Vice President and Chief Financial Officer (“CFO”) of the Company, will transition from her current role, effective May 1, 2026. Following her transition from Executive Vice President and CFO, Ms. Hall will continue to support the Company in an advisory capacity for a period of one year. The Company also announced that Phillip J. Platt, who currently serves as Senior Vice President, Finance and Chief Accounting Officer of Ingevity, has been appointed as Ms. Hall’s …

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

In the company's wordsOn December 8, 2025, Ingevity issued a press release announcing the CFO and Performance Chemicals leadership transitions, as well as the appointment of Clarence Reid Clontz, Jr. to the role of Senior Vice President, Operations. A copy of the press release announcing the leadership transitions from the Company referenced in this Current Report on Form 8-K (this “Current Report”) is furnished as Exhibit 99.1 to this Current Report. The information furnished under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to …

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

In the company's wordsOn December 8, 2025, Ingevity Corporation (the “Company”) issued a press release announcing the completion of the Company’s previously disclosed portfolio review process and its exploration of strategic alternatives for its Advanced Polymer Technologies segment and Performance Chemicals Road Markings business. A copy of the press release announcing the completion of the portfolio review from the Company is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”). In connection with the Company’s efforts to return meaningful capital to its stockholders, the Company has (as of the date of this Current Report) completed over $30 million in stock …

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

Signed a major agreement (Item 1.01)

A major new contract can change what the company sells, spends or owes.

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

Shared shareholder vote results (Item 5.07)

How shareholders voted on board members and proposals.

Signed a major agreement (Item 1.01)

A major new contract can change what the company sells, spends or owes.

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

Shared financial results (Item 2.02)

New results: figures on this page will update when the full quarterly or annual report is filed.

Shared information with investors (Item 7.01)

Information shared with investors, often a presentation or press release.

Change in its leaders or board (Item 5.02)

New leaders or board members can bring a change in strategy.